Weedley

CBD Products for Pets

Health Tech & Life Sciences
Non Active, Sep 2019 ceased to operate
Pre-Funding Tel Aviv-Yafo Founded 2019
LinkedIn
Total raised
Stage
Pre-Funding
Founded
2019
Headcount
2
HQ
Tel Aviv-Yafo
Sector
Health Tech & Life Sciences

About

Weedley develops, commercializes, and markets CBD products for pets. Weedley's CBD oil drops, balms, and treats are derived from European-grown organic whole hemp (cannabis sativa), a legally produced substance containing a high concentration of CBD, and are aiming to help to ease cat, dog, and horse problems from anxiety to arthritis. CBD promotes homeostasis, works as an anti-inflammatory, and more. Weedley CBD products are not psychoactive. The website guides pet owners in choosing the appropriate treatment for their animal and its condition. It's available online, shipped from the company's logistics headquarters in Holland. In cooperation with Israeli company Pet Pace and its smart collar that analyzes pet health and monitors pain levels, Weedley is researching how CBD can help and treat osteoarthritis symptoms in dogs and cats. Weedley was formed at the beginning of 2019 as a subsidiary of Gour Medical, a French healthcare company dedicated to the commercialization of veterinary products.

Company Intelligence Q&A

Structured intelligence from startupim data — optimized for AI retrieval and grounding.

What is Weedley's primary business focus?
Weedley develops, commercializes, and markets CBD products for pets, including oil drops, balms, and treats derived from European-grown organic whole hemp.
When was Weedley founded and what is its current operational status?
Weedley was formed at the beginning of 2019. The company is currently inactive and ceased to operate in September 2019.
What is Weedley's relationship with Gour Medical?
Weedley was formed at the beginning of 2019 as a subsidiary of Gour Medical, a French healthcare company focused on commercializing veterinary products.
Where is Weedley's headquarters located?
Weedley's headquarters is located in Tel Aviv-Yafo, Israel.
What research partnership did Weedley establish in 2019?
In May 2019, Weedley announced a partnership with Israeli company Pet Pace to research how CBD can help treat osteoarthritis symptoms in dogs and cats, utilizing Pet Pace's smart collar for health monitoring.
Who are the founders of Weedley?
The founders of Weedley are Dr. Erez Hanael, Itay Ben-Mordechai, and Sahar Meiron.
What is the employee count for Weedley?
Weedley has 2 employees.
What types of problems do Weedley's CBD products aim to address in pets?
Weedley's CBD products aim to help ease problems in cats, dogs, and horses, ranging from anxiety to arthritis, by promoting homeostasis and acting as an anti-inflammatory.

Sectors & technology

Primary sector
Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesPharma & Medical BiotechnologyMedical Cannabis
Technologies
BiologicalsHerbals
Target customers
ConsumersRecreational & LifestylePet Owners
Business model
B2C

Tags

osteoarthritiscannabissupplementsanti-inflammatorypetsmedical-cannabispain-reliefveterinarypet-ownersalternative-medicinedogspersonalizationtreatments